Agfa-Gevaert N.V. (AFGVY)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Agfa-Gevaert N.V. (AFGVY) with AI Score 42/100 (Weak). Agfa-Gevaert NV is a global developer, producer, and distributor of analog and digital imaging systems, and IT solutions. Market cap: 0, Sector: Industrials.
Last analyzed: Mar 16, 2026Agfa-Gevaert N.V. (AFGVY) Industrial Operations Profile
Agfa-Gevaert NV, founded in 1867, provides imaging solutions and IT services across various sectors. With a market capitalization of $0.09 billion, the company operates in Offset Solutions, Radiology Solutions, Healthcare IT, and Digital Print & Chemicals, offering analog and digital technologies to a global customer base.
Investment Thesis
Agfa-Gevaert NV presents a mixed investment case. While the company has a long history and a diversified product portfolio, its negative profit margin of -6.4% raises concerns about profitability. The company's beta of 0.58 suggests lower volatility compared to the market. Growth catalysts include expansion in the digital printing and healthcare IT segments, but potential risks include competition and economic downturns. Investors should closely monitor the company's financial performance and strategic initiatives to assess its long-term viability.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.09 billion indicates a small-cap company.
- Negative P/E ratio of -1.00 reflects current unprofitability.
- Gross margin of 30.1% suggests moderate efficiency in production and service delivery.
- Beta of 0.58 indicates lower volatility compared to the overall market.
- No dividend yield, indicating that the company is not currently returning profits to shareholders.
Competitors & Peers
Strengths
- Diversified product portfolio.
- Established presence in multiple markets.
- Strong brand recognition.
- Proprietary technology in key segments.
Weaknesses
- Negative profit margin.
- Limited financial resources.
- Dependence on mature markets.
- Exposure to cyclical industries.
Catalysts
- Ongoing: Expansion in the digital printing market, driven by increasing demand for customized printing solutions.
- Ongoing: Growth in the healthcare IT market, fueled by the need for efficient and integrated healthcare systems.
- Upcoming: Potential partnerships with leading technology companies to enhance product offerings in the imaging and IT sectors.
- Ongoing: Development of innovative products and services in the digital printing and healthcare IT segments.
- Upcoming: Strategic acquisitions to expand market share and geographic reach.
Risks
- Ongoing: Intense competition from established players in the imaging and IT industries.
- Potential: Economic downturns that could reduce demand for the company's products and services.
- Potential: Technological obsolescence that could render the company's products and services outdated.
- Ongoing: Regulatory changes that could impact the company's operations and profitability.
- Potential: Currency fluctuations that could affect the company's financial performance.
Growth Opportunities
- Expansion in Digital Printing: The digital printing market is experiencing significant growth, driven by the increasing demand for customized and short-run printing solutions. Agfa-Gevaert can capitalize on this trend by expanding its portfolio of inkjet printers, inks, and fluids for various industrial applications. The global digital printing market is projected to reach $34.3 billion by 2026, offering substantial growth opportunities for Agfa-Gevaert.
- Healthcare IT Solutions: The healthcare IT market is growing rapidly, driven by the need for efficient and integrated healthcare systems. Agfa-Gevaert can leverage its expertise in picture archiving and communication systems, hospital information systems, and integrated care solutions to capture a larger share of this market. The global healthcare IT market is expected to reach $390.7 billion by 2024, presenting a significant growth opportunity for the company.
- Membrane Technology for Hydrogen Production: With increasing global focus on renewable energy sources, the hydrogen production industry is poised for substantial growth. Agfa-Gevaert's membrane technology for hydrogen production positions it to benefit from this trend. As the demand for hydrogen increases, Agfa-Gevaert can expand its membrane production capacity and secure long-term contracts with hydrogen producers.
- Specialty Films and Foils: Agfa-Gevaert's specialty films and foils for security documents and print media offer a niche market with high barriers to entry. The company can focus on developing innovative and high-security solutions to maintain its competitive advantage in this market. The market for security films and foils is driven by the increasing need to protect valuable documents and prevent counterfeiting.
- Industrial Inkjet Applications: The industrial inkjet market is experiencing growth across various applications, including signs, posters, packaging, and printed electronics. Agfa-Gevaert can expand its portfolio of UV-curable and water-based inks for these applications to capture a larger share of this market. The increasing demand for customized and high-quality printing solutions in industrial settings drives the growth of this market.
Opportunities
- Expansion in emerging markets.
- Growth in digital printing and healthcare IT.
- Development of innovative products and services.
- Strategic partnerships and acquisitions.
Threats
- Intense competition.
- Economic downturns.
- Technological obsolescence.
- Regulatory changes.
Competitive Advantages
- Established brand reputation in the imaging industry.
- Diversified product portfolio across multiple segments.
- Proprietary technology in digital printing and healthcare IT.
- Global sales and distribution network.
About AFGVY
Agfa-Gevaert NV, established in 1867 and headquartered in Mortsel, Belgium, has evolved from a photographic materials manufacturer to a provider of comprehensive imaging solutions and IT services. The company operates through four key segments: Offset Solutions, Radiology Solutions, Healthcare IT, and Digital Print & Chemicals. The Offset Solutions segment caters to commercial, newspaper, and packaging printers, offering integrated prepress and printing solutions, including computer-to-plate systems, pressroom supplies, and workflow optimization software. The Radiology Solutions segment provides analog and digital imaging technology for diagnostic imaging, serving hospitals and imaging centers with X-ray film, digital radiography equipment, and image processing software. The Healthcare IT segment delivers picture archiving and communication systems, hospital information systems, and integrated care solutions. The Digital Print & Chemicals segment offers inkjet printers, inks, and fluids for various industrial applications, including signs, posters, packaging, and printed electronics. Agfa-Gevaert sells its products through its own sales organization and a network of agents and representatives worldwide.
What They Do
- Develops and distributes analog and digital imaging systems.
- Provides IT solutions for various industries.
- Offers integrated prepress and printing solutions for commercial, newspaper, and packaging printers.
- Provides digital radiography equipment and image processing software for diagnostic imaging.
- Delivers picture archiving and communication systems for healthcare providers.
- Offers inkjet printers, inks, and fluids for industrial inkjet applications.
- Provides membranes for hydrogen production.
- Supplies specialty films and foils for security documents.
Business Model
- Sells analog and digital imaging systems.
- Provides IT solutions and services.
- Offers printing solutions and supplies.
- Generates revenue through product sales and service contracts.
Industry Context
Agfa-Gevaert operates in the industrial machinery sector, which is characterized by technological advancements and evolving customer needs. The company faces competition from various players in the imaging and IT solutions markets. Market trends include the increasing adoption of digital printing, the growing demand for healthcare IT solutions, and the shift towards sustainable and eco-friendly products. Agfa-Gevaert's ability to adapt to these trends and differentiate itself from competitors will be crucial for its success.
Key Customers
- Commercial, newspaper, and packaging printers.
- Hospitals and imaging centers.
- Healthcare providers.
- Sign and display printing companies.
- Industrial inkjet application users.
Financials
Chart & Info
Agfa-Gevaert N.V. (AFGVY) stock price: Price data unavailable
Latest News
-
Agfa provides update on payment of the receivable related to the sale of Offset Solutions division
Yahoo! Finance: AFGVY News · Feb 16, 2026
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AFGVY.
Price Targets
Wall Street price target analysis for AFGVY.
MoonshotScore
What does this score mean?
The MoonshotScore rates AFGVY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Pascal Juery
CEO
Pascal Juery serves as the CEO of Agfa-Gevaert N.V., leading a workforce of 4765 employees. His career spans various leadership roles in the chemical and industrial sectors. He brings extensive experience in strategic management, operational excellence, and business development. His educational background includes advanced degrees in engineering and business administration, providing him with a strong foundation for leading a technology-driven company.
Track Record: Under Pascal Juery's leadership, Agfa-Gevaert has focused on strategic transformation and innovation. Key achievements include streamlining operations, expanding into new markets, and developing innovative products in digital printing and healthcare IT. He has also overseen efforts to improve the company's financial performance and enhance its competitive position in the global market.
Agfa-Gevaert N.V. ADR Information Unsponsored
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. AFGVY is an ADR representing shares of Agfa-Gevaert N.V., a Belgian company. This allows U.S. investors to invest in Agfa-Gevaert without dealing with foreign exchanges.
- Home Market Ticker: Euronext Brussels, Belgium
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: AFGV
AFGVY OTC Market Information
The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited financial disclosure and may not meet the listing requirements of major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the lack of regulatory oversight and transparency compared to listed companies.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure.
- Lack of regulatory oversight.
- Potential for price manipulation.
- Limited trading volume and liquidity.
- Higher risk of fraud and scams.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive position.
- Evaluate the management team and their track record.
- Research the company's industry and market trends.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor.
- Established history of operations.
- Presence of a recognized management team.
- Availability of some financial information.
- Operation in a regulated industry (imaging, healthcare).
- Active website and investor relations.
Agfa-Gevaert N.V. Stock: Key Questions Answered
What does Agfa-Gevaert N.V. do?
Agfa-Gevaert N.V. develops, produces, and distributes a range of analog and digital imaging systems and IT solutions globally. Its operations are divided into four segments: Offset Solutions, providing printing solutions; Radiology Solutions, offering diagnostic imaging technology; Healthcare IT, delivering healthcare information systems; and Digital Print & Chemicals, supplying inkjet printing solutions and specialty films. The company serves diverse industries, including printing, healthcare, and industrial applications.
What do analysts say about AFGVY stock?
As of March 16, 2026, formal analyst ratings for AFGVY are limited due to its OTC market listing. Key valuation metrics include a negative P/E ratio, reflecting current unprofitability, and a gross margin of 30.1%. Growth considerations center on the company's ability to capitalize on digital printing and healthcare IT market trends. Investors should monitor financial performance and strategic initiatives for future growth potential.
What are the main risks for AFGVY?
Agfa-Gevaert faces several risks, including intense competition in the imaging and IT industries, potential economic downturns impacting demand, and the threat of technological obsolescence. Regulatory changes and currency fluctuations also pose risks to the company's operations and profitability. The company's negative profit margin and limited financial resources further exacerbate these challenges, requiring careful risk management.
What are the key factors to evaluate for AFGVY?
Agfa-Gevaert N.V. (AFGVY) currently holds an AI score of 42/100, indicating low score. Key strength: Diversified product portfolio.. Primary risk to monitor: Ongoing: Intense competition from established players in the imaging and IT industries.. This is not financial advice.
How frequently does AFGVY data refresh on this page?
AFGVY prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven AFGVY's recent stock price performance?
Recent price movement in Agfa-Gevaert N.V. (AFGVY) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diversified product portfolio.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider AFGVY overvalued or undervalued right now?
Determining whether Agfa-Gevaert N.V. (AFGVY) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying AFGVY?
Before investing in Agfa-Gevaert N.V. (AFGVY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available for AFGVY due to its OTC listing.
- Financial data based on available reports and may not be fully comprehensive.
- AI analysis pending for AFGVY.